Quick Summary:
The global Emergency Contraceptive Pills market is poised for significant growth in the coming years, making now the perfect time to gain critical insights into this expanding sector. This comprehensive market research report, which forecasts the market to reach US$1.1 Billion by 2030, provides essential information to help businesses make well-informed decisions and remain competitive in a dynamic market.
The report not only reveals important details about key market segments, including Combination Pills and Progestin Pills, but also offers in-depth analysis of notable geographic markets such as the U.S., China, Japan, Canada, and Germany. Key players in this field such as Bayer AG, Gedeon Richter PLC, and Teva Pharmaceutical Industries Ltd., are profiled, providing valuable insights into their operations and market shares. In addition, this report comes with exclusive access to our online interactive peer-to-peer collaborative bespoke updates, digital archives, a research platform, and complimentary updates for one year.
Global Emergency Contraceptive Pills Market to Reach $1.1 Billion by 2030
The global market for Emergency Contraceptive Pills estimated at US$910.7 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2022-2030. Combination Pills, one of the segments analyzed in the report, is projected to record 3.2% CAGR and reach US$484.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Progesterone Pills segment is readjusted to a revised 2.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $245.5 Million, While China is Forecast to Grow at 3.6% CAGR
The Emergency Contraceptive Pills market in the U.S. is estimated at US$245.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$210 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.Select Competitors (Total 46 Featured) -
- Bayer AG
- Cooper Pharma Limited
- Gedeon Richter PLC
- HRA Pharma
- Lupin Ltd.
- Mankind Pharma Ltd.
- Pfizer, Inc.
- Piramal Enterprises Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zhejiang Xianju Pharmaceutical Co Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Emergency Contraceptive Pills?
What is the growth rate of the Global Market for Emergency Contraceptive Pills?
What is the forecasted size of the Global Market for Emergency Contraceptive Pills?
Who are the key companies in the Global Market for Emergency Contraceptive Pills?
| Report Attribute | Details |
|---|---|
| No. of Pages | 246 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 910.7 Million |
| Forecasted Market Value ( USD | $ 1100 Million |
| Compound Annual Growth Rate | 2.4% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Cooper Pharma Limited
- Gedeon Richter PLC
- HRA Pharma
- Lupin Ltd.
- Mankind Pharma Ltd.
- Pfizer, Inc.
- Piramal Enterprises Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zhejiang Xianju Pharmaceutical Co Ltd.
